sábado, 24 de junio de 2017
Sickle Cell Disease and Public Health
New supplement from the American Journal of Preventive Medicine describes the state of sickle cell disease related care in the United States.
The Genetic Testing Registry (GTR®) provides a central location for voluntary submission of genetic test information by providers. The scope includes the test's purpose, methodology, validity, evidence of the test's usefulness, and laboratory contacts and credentials. The overarching goal of the GTR is to advance the public health and research into the genetic basis of health and disease.